- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
The Effects of ERCC1 Expression Levels on the Chemo-resistance of Breast Cancer Patients Treated with Platinum based Adjuvant Chemotherapy | ||
| Iraqi Journal of Biotechnology | ||
| Article 1, Volume 16, Issue 1, 2017, Pages 106-110 | ||
| Authors | ||
| Ban A. Abd. AL majeed; Mohammad I. Nader; Suhad K. Karim | ||
| Abstract | ||
| Excision repair cross-complementing 1 (ercc1) is reported to be involved in the sensitivity of cancer patients to platinum-based chemotherapy. The present study to evaluate the effects of ERCC1 expression on the chemosensitivity of platinum agents in breast cancer. ercc1 expression levels were measured by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The results demonstrated patients with low ercc1 levels had chemosensitive than those with high ercc1 levels. These results suggest that overexpression of ercc1 is correlated with platinum drug resistance in breast cancer patients .The patients with low levels of ercc1 expression demonstrate a benefit from platinum-based adjuvant chemotherapy. | ||
| Keywords | ||
| ercc; Breast Cancer; platinum chemotherapy; qRT; PCR | ||
|
Statistics Article View: 146 PDF Download: 111 |
||